Esposito S, Birlutiu V, Jarcuska P, Perino A, Man SC, Vladareanu R et al.
Immunogenicity and safety of human papillomavirus-16/18 AS04-adjuvanted vaccine administered
according to an alternative dosing schedule compared with the standard dosing schedule in healthy
women aged 15 to 25 years: results from a randomized study.
Ped Inf Dis J 2011;
Download Bibliographical Data